|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.23 USD | -1.72% |
|
-3.05% | +23.60% |
| 07-15 | Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform | MT |
| 07-14 | Bruker Corporation acquired DISQVER Clinical Metagenomics Platform of Noscendo GmbH. | CI |
| Market Cap | 8.86B 7.75B 7.15B 6.59B 12.42B 854B 12.69B 85.44B 33.6B 418B 33.29B 32.56B 1,439B | P/E 2026 * |
57.5x | P/E 2027 * | 43.7x |
|---|---|---|---|---|---|
| Enterprise Value | 10.34B 9.04B 8.34B 7.69B 14.49B 996B 14.81B 99.71B 39.22B 488B 38.85B 38B 1,680B | EV / Sales 2026 * |
2.88x | EV / Sales 2027 * | 2.71x |
| Free-Float |
60.72% | Yield 2026 * |
0.34% | Yield 2027 * | 0.35% |
Last Transcript: Bruker Corporation
| 1 day | -1.72% | ||
| 1 week | -3.05% | ||
| Current month | -3.24% | ||
| 1 month | +6.40% | ||
| 3 months | +43.07% | ||
| 6 months | +20.33% | ||
| Current year | +23.60% |
| 1 week | 56.74 |  | 61.21 |
| 1 month | 54.9 | | 63.04 |
| Current year | 32.36 | | 64.54 |
| 1 year | 28.53 | | 64.54 |
| 3 years | 28.53 | | 94.86 |
| 5 years | 28.53 | | 94.86 |
| 10 years | 19.58 | | 94.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Laukien
CEO | Chief Executive Officer | 66 | 1991-01-31 |
Gerald Herman
DFI | Director of Finance/CFO | 68 | 2018-03-16 |
Thorsten Thiel
SAM | Sales & Marketing | - | 2010-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Linton
BRD | Director/Board Member | 79 | 2000-01-31 |
Frank Laukien
CHM | Chairman | 66 | 1991-01-31 |
Richard Packer
BRD | Director/Board Member | 68 | 2007-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Other | President BMID Group | 10,154 | 0.0067% | ||
| 6/15/26 | Fiscal year | Executive/Senior Manager | 6,000 | 0.0039% | ||
| 5/15/26 | Free | Director | 2,886 | 0.0019% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.72% | -3.05% | +38.02% | -20.75% | 9.02B | |
| -1.97% | +1.03% | +25.30% | +1.37% | 202B | |
| -0.58% | +2.40% | +4.64% | -14.27% | 145B | |
| -14.15% | -15.08% | -33.08% | -2.38% | 142B | |
| -1.32% | -1.65% | -57.93% | -16.31% | 66.32B | |
| -2.40% | -7.03% | +12.54% | -7.47% | 50.58B | |
| -0.11% | +1.53% | -24.62% | -31.81% | 44.81B | |
| -3.41% | -2.11% | +12.98% | +11.17% | 38.44B | |
| -2.44% | -1.98% | +24.27% | +36.75% | 37.13B | |
| -4.00% | -2.52% | -17.27% | -22.32% | 29.89B | |
| Average | -1.73% | -2.37% | -1.52% | -6.60% | 76.56B | |
| Weighted average by Cap. | -1.31% | -2.17% | -2.64% | -5.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.59B 3.14B 2.89B 2.67B 5.03B 346B 5.14B 34.59B 13.61B 169B 13.48B 13.18B 583B | 3.74B 3.27B 3.02B 2.78B 5.24B 360B 5.36B 36.07B 14.19B 176B 14.05B 13.74B 608B |
| Net income | 155M 135M 125M 115M 217M 14.92B 222M 1.49B 587M 7.31B 582M 569M 25.16B | 203M 178M 164M 151M 285M 19.57B 291M 1.96B 770M 9.58B 763M 746M 32.99B |
| Net Debt | 1.48B 1.29B 1.19B 1.1B 2.07B 143B 2.12B 14.27B 5.61B 69.82B 5.56B 5.44B 240B | 1.27B 1.11B 1.02B 943M 1.78B 122B 1.82B 12.23B 4.81B 59.86B 4.77B 4.66B 206B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | US$58.23 | -1.72% | 2,325,639 |
| 26-07-16 | US$59.25 | +1.01% | 1,556,775 |
| 26-07-15 | US$58.66 | -1.96% | 1,920,724 |
| 26-07-14 | US$59.83 | +1.46% | 1,468,304 |
| 26-07-13 | US$58.97 | -1.81% | 1,752,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRKR Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
